К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

Letrozole, anastrozole, exemestane: aromatase inhibitors for breast cancer

Aromatase inhibitors are hormone therapy after menopause. How they work, how they differ from tamoxifen, why joints ache and why bone density needs checking.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026

In short

Aromatase inhibitors are hormone therapy tablets: letrozole, anastrozole and exemestane. After menopause, estrogen is made mainly with the help of the enzyme aromatase, and these drugs block it. They work in hormone receptor-positive cancer — with positive ER and/or PR.

How it appears in your prescription

  • ‘Letrozole 2.5 mg once a day’ / ‘Anastrozole 1 mg’ / ‘Exemestane 25 mg’.
  • ‘Aromatase inhibitor + ovarian suppression’ — before menopause.
  • ‘Letrozole + palbociclib (ribociclib, abemaciclib)’ — in metastatic cancer, together with CDK4/6 inhibitors.

What it means

According to the US National Cancer Institute, in postmenopausal women aromatase inhibitors lower the risk of recurrence more than tamoxifen. They are taken for 5 years or longer — straight away or after a few years of tamoxifen. In metastatic cancer they are most often combined with CDK4/6 inhibitors.

Side effects

Joint pain and stiffness, hot flashes, dryness of mucous membranes and raised cholesterol. The main long-term risk is bone loss and fractures. That is why a bone density scan is done before and during treatment, calcium and vitamin D are taken as prescribed, and bone-protecting drugs are added if osteoporosis develops.

Questions to ask your doctor

  • Which of the three drugs am I on, and why?
  • How often should my bone density be checked?
  • What should I do if my joints hurt so much it affects daily life?

Sources

  1. Letrozole — National Cancer Institute
  2. Anastrozole — National Cancer Institute
  3. Study Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen — National Cancer Institute

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles